| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |